EUVIMEDEUVIMED entdecken
Open Access

Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment

Margarita L Zuley iD, Jonathan Silverstein iD, Durwin Logue, Richard S Morgan, Rohit Bhargava iD, Priscilla F McAuliffe, Adam M Brufsky iD, Andriy I Bandos iD, Robert M Nishikawa iD

JCO Clinical Cancer Informatics · 2024

DOI: 10.1200/cci.23.00193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2024. Verfasst von Margarita L Zuley und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh, School of Medicine & University of Pittsburgh Medical Center, Department of Radiology, Division of Breast Imaging, Pittsbur…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE In the United States, a comprehensive national breast cancer registry (CR) does not exist. Thus, care and coverage decisions are based on data from population subsets, other countries, or models. We report a prototype real-world research data mart to assess mortality, morbidity, and costs for breast cancer diagnosis and treatment. METHODS With institutional review board approval and Health Insurance Portability and Accountability Act (HIPPA) compliance, a multidisciplinary clinical and research data warehouse (RDW) expert group curated demographic, risk, imaging, pathology, treatment, and outcome data from the electronic health records (EHR), radiology (RIS), and CR for patients having breast imaging and/or a diagnosis of breast cancer in our institution from January 1, 2004, to December 31, 2020. Domains were defined by prebuilt views to extract data denormalized according to requirements from the existing RDW using an export, transform, load pattern. Data dictionaries were included. Structured query language was used for data cleaning. RESULTS Five-hundred eighty-nine elements (EHR 311, RIS 211, and CR 67) were mapped to 27 domains; all, except one containing CR elements, had cancer and noncancer cohort views, resulting in a total of 53 views (average 12 elements/view; range, 4-67). EHR and RIS queries returned 497,218 patients with 2,967,364 imaging examinations and associated visit details. Cancer biology, treatment, and outcome details for 15,619 breast cancer cases were imported from the CR of our primary breast care facility for this prototype mart. CONCLUSION Institutional real-world data marts enable comprehensive understanding of care outcomes within an organization. As clinical data sources become increasingly structured, such marts may be an important source for future interinstitution analysis and potentially an opportunity to create robust real-world results that could be used to support evidence-based national policy and care decisions for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansUnited StatesFemaleData WarehousingElectronic Health RecordsRegistriesDiagnostic Imaging

Autor:innen und Institutionen

  • University of Pittsburgh, School of Medicine & University of Pittsburgh Medical Center, Department of Radiology, Division of Breast Imaging, Pittsburgh, PA.
  • University of Pittsburgh, School of Medicine, Department of Biomedical Informatics, Pittsburgh, PA.
  • University of Pittsburgh, School of Medicine, Department of Radiology, Imaging Research, Pittsburgh, PA.
  • University of Pittsburgh, School of Medicine, Department of Pathology and Pathology at Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA.
  • University of Pittsburgh, School of Medicine, Department of Surgery and Breast Surgical Oncology at Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA.
  • University of Pittsburgh, School of Medicine & University of Pittsburgh Medical Center, Division of Hematology/Oncology, Pittsburgh, PA.

ORCID-Profile: Margarita L Zuley, Jonathan Silverstein, Rohit Bhargava, Adam M Brufsky, Andriy I Bandos, Robert M Nishikawa

Förderung

  • NCI NIH HHS

Zitieren

APA

Zuley, M. L., Silverstein, J., Logue, D., Morgan, R. S., Bhargava, R., McAuliffe, P. F., Brufsky, A. M., Bandos, A. I., & Nishikawa, R. M. (2024). Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.23.00193

Vancouver

Zuley ML, Silverstein J, Logue D, Morgan RS, Bhargava R, McAuliffe PF, et al. Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment. JCO Clinical Cancer Informatics. 2024. doi:10.1200/cci.23.00193

BibTeX
@article{Zuley2024,
  author = {Zuley, Margarita L and Silverstein, Jonathan and Logue, Durwin and Morgan, Richard S and Bhargava, Rohit and McAuliffe, Priscilla F and Brufsky, Adam M and Bandos, Andriy I and Nishikawa, Robert M},
  title = {Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment},
  journal = {JCO Clinical Cancer Informatics},
  year = {2024},
  doi = {10.1200/cci.23.00193}
}
Kostenlos starten →